Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/20665| Title: | Trastuzumab combined with pegylated liposomal doxorubicin in patients with metastatic breast cancer. phase II Study of the Hellenic Cooperative Oncology Group (HeCOG) with biomarker evaluation |
| Institution and School/Department of submitter: | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής |
| Keywords: | Adult,Aged,Antibodies, Monoclonal/*administration & dosage/adverse effects,Antibodies, Monoclonal, Humanized,Antineoplastic Combined Chemotherapy Protocols/*therapeutic use,Breast Neoplasms/chemistry/*drug therapy/mortality,Doxorubicin/administration & dosage/adverse effects/*analogs & derivatives,Humans,Middle Aged,PTEN Phosphohydrolase/analysis,Polyethylene Glycols/*administration & dosage/adverse effects,Protein Kinases/analysis,Receptor, erbB-2/analysis,TOR Serine-Threonine Kinases,Ventricular Function, Left/drug effects |
| URI: | https://olympias.lib.uoi.gr/jspui/handle/123456789/20665 |
| ISSN: | 1423-0232 |
| Link: | http://www.ncbi.nlm.nih.gov/pubmed/19262067 http://content.karger.com/ProdukteDB/produkte.asp?doi=10.1159/000207504 |
| Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ |
Files in This Item:
There are no files associated with this item.
This item is licensed under a Creative Commons License
